NAPAGE: NAb-PAclitaxel and GEmcitabine in Advanced Soft Tissue Sarcoma. A Multicenter Open-label Single Arm Phase Ib/IIa Trial
Phase of Trial: Phase I/II
Latest Information Update: 22 May 2019
Price : $35 *
At a glance
- Drugs Gemcitabine (Primary) ; Paclitaxel (Primary)
- Indications Soft tissue sarcoma
- Focus Adverse reactions; Therapeutic Use
- Acronyms NAPAGE
- 05 Oct 2018 Status changed from not yet recruiting to recruiting.
- 25 Sep 2018 Planned initiation date changed from 1 Aug 2018 to 1 Nov 2018.
- 17 May 2018 New trial record